La vendita allo scoperto per TriSalus Life Sciences dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di TriSalus Life Sciences. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

TriSalus Life Sciences (NASDAQ:TLSI) Azioni, Report sulle vendite allo scoperto

TriSalus Life Sciences

TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

TriSalus Life Sciences, Inc. - Common Stock

TriSalus Life Sciences Inc

Chinese trade flows exhibited momentum in April despite President Donald Trump&#8217;s tariff war against <a target="_blank" href="https://www.benzinga.com/topic/chinese-stocks" rel="noreferrer noopener">its trading partners</a>.
Trump&#8217;s tariff relief on electronic products and pause of reciprocal tariffs against most countries posed a tailwind, signaling Asia suffered less trade disruption.
Chinese e-commerce juggernaut Alibaba Group Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), the country&#8217;s tech barometer, trades higher on Tuesday.
Also Read: <a target="_blank" href="https://www.benzinga.com/government/regulations/25/04/44874701/temu-and-shein-to-raise-prices-amid-us-tariffs-slash-ad-spend-on-apple-meta" rel="noreferrer noopener">Temu And Shein To Raise Prices Amid US Tariffs, Slash Ad Spend On Apple, Meta</a>
Electric vehicle companies, including NIO Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>), Li Auto Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>), and XPeng Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>), are also trading upwards Tuesday.
Temu parent PDD Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) and Baidu, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) also rose on Tuesday after Treasury Secretary Scott Bessent reportedly said he expects de-escalation with China.
Chinese ports processed 6.3 million containers in the seven days through April 20,&nbsp;up by 10% from the same week last year, Bloomberg <a target="_blank" href="https://www.bloomberg.com/news/articles/2025-04-22/china-trade-immune-so-far-to-tariffs-with-growth-pickup-in-april?srnd=phx-technology&amp;sref=TBDibEcD" rel="noreferrer noopener">reported</a>, citing official data.
Additionally, Washington&#8217;s exemption on electronics from reciprocal tariffs provided some relief for Chinese exporters since the exclusion covers over $100 billion in goods from the country, Bloomberg cited&nbsp;Gerard DiPippo data.
Washington and Beijing have imposed levies over 100% on most of their bilateral commercial flows.
The Port of Los Angeles&nbsp;expects&nbsp;13 ships from Chinese ports to anchor this week, and over 120,000 containers from all origins will be overloaded this week, just below the level in the prior seven days.
Air freight also benefited,&nbsp;as U.S. shoppers stockpiled Temu and Shein products before the U.S. government&nbsp;ended an exemption.
However, it&#8217;s not all good for China, as Bloomberg cited Caixin Global as stating that the volume of cargo carried on the China-Europe train links&nbsp;declined by 10% in the first quarter.
Reportedly, China&#8217;s Xi Jinping could propose a plum deal to Europe as it proposed to tap the <a target="_blank" href="https://www.benzinga.com/news/global/25/04/44892820/xi-jinping-could-woo-europe-with-a-potential-china-deal-to-undercut-trumps-tariff-strategy-expert-warns" rel="noreferrer noopener">strained US-EU relations</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44837898/chinese-stocks-slide-as-trump-tariffs-surge-to-245-sparking-fears-of-price-hikes-and-delistings" target="_blank" rel="noreferrer noopener">US Tariff Hikes Weigh on Chinese Stocks, With Alibaba, Nio, and Baidu Among Biggest Decliners</a></li>
</ul>
Photo via Shutterstock

News

Topics

Movers

Media

BABA

BIDU

Citigourp Global Markets 2% Protected Notes Linked To The Djia

XPEV

Why Are US-Listed Chinese Stocks Trading Higher On Tuesday?

Investors are gearing up for Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) to release its quarterly results after<a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44930495/wall-street-rebounds-ahead-of-tesla-earnings-dow-adds-1000-points-bitcoin-hits-91000-whats-driving-markets-tuesday"> Tuesday's closing bell.&nbsp;</a>
A Benzinga poll finds that a majority of respondents think that the EV giant will miss consensus estimates for the quarter.&nbsp;&nbsp;
Read Next: <a href="https://www.benzinga.com/25/04/44925313/tesla-q1-earnings-preview-shareholders-analysts-want-answers-on-guidance-tariffs-fsd-and-more">Tesla Q1 Earnings Preview: Shareholders, Analysts Want Answers On Guidance, Tariffs, FSD And More</a>
Estimates: Analysts expect Tesla to report first-quarter revenue of $21.35 billion, up from $21.30 billion in last year&#8217;s first quarter, according to data <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0421">from Benzinga Pro.</a>
Analysts expect the company to report first-quarter earnings per share of 41 cents, down from 45 cents in last year&#8217;s first quarter. The company beat earnings per share estimates in the fourth quarter.
Tesla has missed analyst estimates for earnings per share in five of the last six quarters and six of the last 10 quarters overall.
What To Expect: Tesla sales are falling, especially in Europe and CEO Elon Musk&#8217;s focus could be elsewhere, said Jay Woods, Freedom Capital Markets chief global strategist.
&#8220;Tesla remains one of the most volatile and discussed stocks in the world. Elon Musk&#8217;s political bent has made this stock a lightning rod of discussion,&#8221; Woods said in a weekly newsletter.
Wedbush analyst Daniel Ives has argued that Musk should be focusing more time on Tesla and has also questioned how much "brand damage" has been done by the CEO's<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44933432/tesla-in-code-red-situation-as-analyst-flags-6-threats-tied-to-musks-government-role"> political involvement</a>.&nbsp;
Poll Results: Benzinga recently polled <a href="https://www.benzinga.com/premarket-prep">Premarket Playbook</a> viewers to predict Tesla's earnings results.&nbsp;
The poll results were:
<ul>
<li>Miss: 68%</li>
<li>Beat: 19%</li>
<li>Inline: 11%</li>
</ul>
The poll found more than half of respondents expect Tesla to miss analysts' estimates and only 19% see the company beating the consensus expectations. The remaining 11% of respondents said they see Tesla's Q1 results inline with analysts' estimates.&nbsp;
TSLA Price Action: Tesla stock was up 3.65% to $235.73 heading into Tuesday's closing bell, according to data from<a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw"> Benzinga Pro.&nbsp;</a>
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/04/44903087/amazon-stock-downgraded-price-target-slashed-as-tariffs-create-uncertainty">Amazon Stock Downgraded, Price Target Slashed As Tariffs Create Uncertainty </a></li>
</ul>
Image: Shutterstock

Earnings

Large Cap

Exclusives

Tech

TSLA

Will Tesla Beat The Street? 68% Expect Something Markets May Not Be Ready For

JERSEY CITY, N.J., April 22, 2025 (GLOBE NEWSWIRE) -- Gotham FC, the preeminent top-tier professional women's soccer club in the New York region, announced on Tuesday the multi-year extension of its marquee partnership with <a href="https://www.globenewswire.com/Tracker?data=3UuSMqmyDFRtA7Mr_RJnfW6WFtIbb_KHCbujpF3yn3uzCNuupfpkFYJu1c2O0DoLuueKSQQk7MW5lbFwdfSCOw==">CarMax</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMX#NYSE">KMX</a>), the nation's largest retailer of used cars. The renewed partnership continues the dynamic relationship between the two brands, deepening their shared commitment to community and the growth of women's sports.&nbsp;
As part of this renewed collaboration, CarMax will remain the front-of-kit sponsor of Gotham FC, with prominent logo placement on the club's kits. CarMax is also the presenting partner of the Gotham FC regular season and Fan Fest at Sports Illustrated Stadium in addition to regional game broadcasts on MSG Networks, the Gotham FC player of the match award, the CarMax Kids program and an original content series set to be released later this season.&nbsp;&nbsp;

Gotham FC Announces Multi-Year Extension Of Marquee Partnership With CarMax

Plug Power Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) shares are trading higher by 11.5% to 88 cents Tuesday afternoon. The stock is rebounding sharply amid a broad Wall Street rally, sparked by potential <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44930495/wall-street-rebounds-ahead-of-tesla-earnings-dow-adds-1000-points-bitcoin-hits-91000-whats-driving-markets-tuesday">easing of geopolitical concerns.</a>
What To Know: Tuesday&#8217;s market bounce followed Monday's sell-off, which was triggered by the Trump administration&#8217;s <a href="https://www.benzinga.com/government/regulations/25/04/44904179/wall-street-sinks-dollar-slides-as-trump-ramps-up-fed-attacks-whats-driving-markets-monday">pressure</a> on the Federal Reserve. On Tuesday, major indices all surged more than 2.5%, with the Nasdaq-100 gaining over 400 points.
Sentiment improved further after U.S. Treasury Secretary Scott Bessent <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44930495/wall-street-rebounds-ahead-of-tesla-earnings-dow-adds-1000-points-bitcoin-hits-91000-whats-driving-markets-tuesday">signaled</a> a potential easing in U.S.-China tensions.
Plug Power shares have also been volatile in recent sessions following last week&#8217;s launch of a major hydrogen liquefaction facility in Louisiana, developed in partnership with Olin Corporation. The company says the facility adds 15 metric tons of daily capacity and strengthens Plug's domestic supply chain.
Despite financial headwinds—<a href="https://www.benzinga.com/news/25/04/44614627/plug-power-stock-plagued-by-earnings-miss-cost-cuts-280m-capital-raise-in-march">including a fourth-quarter earnings miss</a>, a $280 million capital raise, and a sharp revenue guidance cut—CEO Andy Marsh remains bullish, taking 50% of his salary in company stock to signal confidence in the company's long-term outlook.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44933432/tesla-in-code-red-situation-as-analyst-flags-6-threats-tied-to-musks-government-rol">Tesla In &#8216;Code Red Situation&#8217; As Analyst Flags 6 Threats Tied To Musk&#8217;s Government Role</a>
<h2 class="wp-block-heading">How To Buy PLUG Stock</h2>
By now you're likely curious about how to participate in the market for Plug Power &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, PLUG has a 52-week high of $4.88 and a 52-week low of $0.76.

PLUG

Plug Power Stock Is Up 11% Tuesday: What's Going On?

Sen. Elizabeth Warren (D-MA) is raising concerns after President Donald Trump <a href="https://www.benzinga.com/25/04/44872241/trump-criticizes-fed-chair-powell-as-too-late-and-wrong-china-cuts-us-oil-imports-by-90-shifts-to-canada-over-tariffs-nvidia-follows-us-rules-on-china-sales-amid-trade-tensions-top-headlines-while-the-us-slept">once again criticized</a> Federal Reserve Chair Jerome Powell and hinted at firing him before the end of his term.
Speaking to <a href="https://www.youtube.com/watch?v=GApxUtKDnEM">CNBC</a> last week, Warren said that while the president cannot legally fire Powell, she wouldn't put anything past Trump. "This is a president who has shown himself willing to violate laws," she said. "If Chairman Powell can be fired by the president of the United States, it will crash the markets."
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li>Invest in the future of digital engagement: <a href="https://www.benzinga.com/money/vatom-adv">Own a piece of the $100 billion Metaverse for just $500</a>.</li>
</ul>
<h2 class="wp-block-heading">Warren Warns of Financial Chaos</h2>
Warren, a <a href="https://www.benzinga.com/news/24/06/39325582/elizabeth-warren-slams-fed-chair-jerome-powell-on-tackling-violation-of-banks-insider-trading-policy">longtime critic</a> of Powell's decisions on interest rates and regulation, said it's still imperative that the Federal Reserve remain independent. "The infrastructure that keeps this stock market strong…is the idea that the big pieces move independent of the politics," she said. "If the New York Stock Exchange, if interest rates in the United States are subject to a president who just wants to wave his magic wand…then we are no different from a two-bit dictatorship."
Her comments came just hours after Trump on Thursday <a href="https://truthsocial.com/@realDonaldTrump/posts/114352766082542122">posted</a> on Truth Social that, "Powell&#8217;s termination cannot come fast enough!" Trump accused Powell of being &#8220;too late and wrong&#8221; on interest rates and blamed him for slowing the economy.
Later that day, Trump doubled down, <a href="https://www.youtube.com/watch?v=r925D_I5GtY">telling reporters</a>, &#8220;I don&#8217;t think he&#8217;s doing the job. He&#8217;s too late, always too late&#8230; If I want him out, he&#8217;ll be out of there real fast, believe me.&#8221;
Trending: <a href="https://www.benzinga.com/money/investing-in-the-midwest-why-multifamily-real-estate-is-a-winning-strategy">This investment company boasts a 33.85% internal rate of return (IRR) for its realized projects, allowing accredited investors to earn passive returns and avoid the headaches of being a landlord.</a>
<h2 class="wp-block-heading">A Pattern of Pay-to-Play?</h2>
Warren also accused Trump of using tariffs to reward allies and donors while hurting competitors. She pointed to Trump's <a href="https://www.benzinga.com/markets/equities/25/02/43876173/apple-ceo-tim-cook-reportedly-meets-trump-as-tariff-impact-looms-on-iphone-sales-and-companys-china-strategy">past interactions</a> with Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) CEO Tim Cook and previous tariff decisions linked to countries where Trump had business interests.
"The problem is, nobody can trust the system," Warren said. "There's no independence, no fairness. It's all, whose palm did you grease?"
In a joint <a href="https://fm.cnbc.com/applications/cnbc.com/resources/editorialfiles/2025/04/16/Warren_Lawmakers_Letter_to_Trump_Administration_on_Corruption_and_Tariffs.pdf">letter</a> to Commerce Secretary Howard Lutnick and Treasury Secretary Scott Bessent, Warren and nearly 50 Senate Democrats criticized the unpredictability and favoritism in Trump's tariff policy. They called for more transparency around companies seeking tariff exemptions.
&#8220;We have not built a strong economy in America based on that kind of pay-to-play,&#8221; she said.
See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.
<h2 class="wp-block-heading">Fed Independence Goes Back Generations</h2>
Warren explained that the Fed's independence has been essential to American financial stability since the Civil War, when the Office of the Comptroller of the Currency was created in 1863 to ensure the integrity of the banking system during wartime.&nbsp;
She pointed out that, ever since, regulators have been kept financially and politically independent to avoid pressure from elected officials or wealthy donors.
&#8220;We need to preserve it not for the politics of the moment, but because overall, that's what keeps the system strong year after year, decade after decade.&#8221;
She warned that letting presidents interfere in monetary policy, especially by threatening job security, undermines that entire framework.&nbsp;
Powell has made it known that he does not believe the president has the authority to remove him. His term as Fed chair ends in May 2026.
Read Next:
<ul>
<li>BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>
Image: Shutterstock

AAPL

Elizabeth Warren Says, 'If Trump Illegally Fires Fed Chair Powell, He'll Crash Our Markets, Cause More Economic Pain To American Families'

General

PhenixFIN On April 17, Parties To Credit Facility Amends Terms Of Credit Facility;  Credit Facility Increased By $12.5 Million To $100 Million; Credit Facility Term Extended To April 17, 2030

When the economy gets shaky and trust in banks starts to slip, people naturally look for alternatives. Lately, one of the most talked-about options isn't gold or real estate, but stablecoins.
At their core, stablecoins are digital currencies designed to keep a steady value. Unlike regular cryptocurrencies that can swing wildly in price, stablecoins are tied to assets like the U.S. dollar, making them a reliable store of value. That reliability is starting to matter more than ever.
Stablecoins are also unbound from the constraints that fiat currencies are exposed to. Imagine a freelancer getting paid from overseas — they often have to use remittance companies or crossborder payment services that either charge high fees or take days to settle. For them, stablecoins are a real lifeline. They're easy to use, don't require a bank account, and work around the clock, no matter where you are in the world.
What's more, there's no mountain of paperwork or approval process. Just download a digital wallet, and you&#8217;re in. That kind of open access is game-changing, especially for the billions of people still excluded from traditional banking systems.
USDT and USDC dominate the stablecoin space right now. Together, they move billions every day and are becoming more accessible across different blockchains. Another emerging class of stablecoins are yield-bearing stablecoins, led by Ethena and Level, that provide users with sustainable yield options in the face of widespread volatility.
Stablecoins are no longer just a crypto-native concept. They're rapidly entering the apps people already use every day. PayPal and Venmo now support stablecoin transfers. Nubank and Revolut are integrating stablecoins directly into their fintech interfaces. Even governments are taking notice—Thailand recently announced it will begin accepting stablecoins for certain forms of payment, signaling growing regulatory openness in Asia. This means users can now send global payments, remit funds across borders, and pay merchants without ever needing to understand how blockchain works.
For the first time, people can use borderless digital dollars inside products they already trust. Merchant adoption is accelerating too, Stripe supports stablecoin payments, and integrations with Apple Pay and Google Pay are on the horizon. With these channels in place, stablecoins are on the verge of becoming default digital money.
But while this benefits human users, it also lays the groundwork for something bigger: a fully AI-compatible currency layer.
Stablecoins started as a bridge between fiat and crypto. But their evolution, enabled by the rapid AI developments, could turn them into the coordination layer for the machine economy.
As autonomous AI agents increasingly participate in financial ecosystems, executing trades, managing supply chains, optimizing liquidity, they'll need access to currencies that are not only stable but programmable, interoperable, and instantly available across different asset classes and chains and backed by different types of assets.
AI manages volatility and uncertainty, but it thrives in stability, just like large language models become more effective when fed large clean datasets. Unlike human traders who might speculate on swings, AI agents are logic-driven. They prioritize efficiency, predictability, and risk minimization. That's why highly stable, on-chain currencies anchored in real-world value and verifiable in real time are quickly becoming critical infrastructure in the age of intelligent automation.
Having a stable, AI-compatible currency layer would mean entire industries will be able to transact autonomously with minimal exposure to volatility and using a wide variety of assets. AI agents could settle across jurisdictions without banking rails and real-world assets could be collateralized and algorithmically stabilized, unlocking new forms of programmable value.
Stablecoins are evolving into smarter, more flexible tools that could change how we interact with money, especially when the world feels anything but stable.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Opinion

Trading Ideas

The Quiet Rise Of The World's New Money Standard

Cryptocurrency markets are trading higher on Tuesday, with Bitcoin reclaiming $91,000 on the back of the <a href="https://in.benzinga.com/markets/cryptocurrency/25/04/44917155/xrp-leads-ethereum-bleeds-as-crypto-investment-products-see-6-million-in-inflows">strongest institutional ETF inflows</a> since January.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$91,549.61</td>
<td>+5.4%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$1,704.37</td>
<td>+8.5%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$144.88</td>
<td>+7%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$2.16&nbsp;</td>
<td>+4.3%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.1723</td>
<td>+9.8%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001325</td>
<td>+7.4%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul>
<li>IntoTheBlock data shows large transaction volume increasing by 80.2% and daily active addresses growing by 19.3%. Transactions greater than $100,000 are up from 5,571 to 8,839 in a single day. Exchanges netflows are down by 661.9%.</li>
<li>Coinglass data reports 108,998 traders were liquidated in the past 24 hours with the total liquidations at $348.20 million.</li>
<li>Glassnode data <a href="https://x.com/glassnode/status/1914689187736940885">shows</a> Bitcoin open interest increased from $28.5 billion to $30.7 billion over the past 24 hours.</li>
</ul>
Notable Developments:
<ul>
<li><a href="https://in.benzinga.com/markets/cryptocurrency/25/04/44919277/xrp-solana-dogecoin-among-72-crypto-related-etfs-awaiting-sec-approval">XRP, Solana, Dogecoin Among 72 Crypto-Related ETFs Awaiting SEC Approval,</a></li>
<li><a href="https://in.benzinga.com/markets/cryptocurrency/25/04/44926052/bitcoin-reclaims-90000-is-digital-gold-heading-to-100000-next">Bitcoin Reclaims $90,000: Is &#8216;Digital Gold&#8217; Heading To $100,000 Next?</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44917155/xrp-leads-ethereum-bleeds-as-crypto-investment-products-see-6-million-in-inflows">XRP Leads, Ethereum Bleeds As Crypto Investment Products See $6 Million In Inflows</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44907123/ripple-coinbase-solana-among-crypto-firms-contributing-over-12m-to-trumps-inauguration-fund">Ripple, Coinbase, Solana Among Crypto Firms Contributing Over $12M To Trump&#8217;s Inauguration Fund</a></li>
</ul>
Top Gainers:
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Fartcoin (CRYPTO: FARTCOIN)</td>
<td>$1.07</td>
<td>+23.2%</td>
</tr>
<tr>
<td>Curve DAO Token (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/crv/usd">CRV</a>) </td>
<td>$0.6896</td>
<td>+18.5%</td>
</tr>
<tr>
<td>Immutable (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">IMX</a>)</td>
<td>$0.5565</td>
<td>+18%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto trader ElonMoney warns that if Bitcoin fails to hold above $91,200 and slips below the 90-day Volume Weighted Average Price (VWAP), a drop toward the 7-day VWAP near $85,500 is likely.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">If <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> can't hold above 91,200 and drops back below the 90D VWAP, we're heading back down to test support at the 7D VWAP around 85,500. <a href="https://t.co/r5e6031tRI">pic.twitter.com/r5e6031tRI</a>
&mdash; elonmoney.hl (@0xelonmoney) <a href="https://twitter.com/0xelonmoney/status/1914740718658105821?ref_src=twsrc%5Etfw">April 22, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto Chase <a href="https://x.com/Crypto_Chase/status/1914738989938221233">identifies</a> $93,500 as a potential distribution zone, noting that the recent sharp rally lacked liquidity sweeps or meaningful retests. 
He remains cautious, flagging the risk of a sudden reversal pointing out that up-only moves often precede down-only corrections, a pattern he's seen play out frequently in past cycles.
Analyst Benjamin Cowen <a href="https://x.com/intocryptoverse/status/1914728548243529792">highlighted</a> a classic Bitcoin pattern playing out around key moving average crosses: first a dump into the cross, followed by a countertrend rally once it completes. 
This familiar setup often serves as a shakeout before a short-term bounce trap late participant.
On-chain insights from CryptoQuant reveal that spot demand for Bitcoin continues to weaken, despite slowing its decline. 
The firm notes that demand momentum is now at its most negative level since October 2024, signaling underlying fragility. 
Without a turnaround in both demand and momentum, a sustained rally remains unlikely.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Bitcoin spot demand is still falling, but not as fast. Demand momentum just hit its most negative level since Oct '24. Until both recover, sustained upside remains unlikely. <a href="https://t.co/qYx6pryfHC">pic.twitter.com/qYx6pryfHC</a>
&mdash; CryptoQuant.com (@cryptoquant_com) <a href="https://twitter.com/cryptoquant_com/status/1914747578173768134?ref_src=twsrc%5Etfw">April 22, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44928800/bitcoin-is-dependent-on-the-us-not-a-non-dollar-asset-peter-schiff-says">Bitcoin Is Dependent On The US, Not A &#8216;Non-Dollar Asset,&#8217; Peter Schiff Says</a></li>
</ul>
Image: Shutterstock

$BTC

$CRV

$DOGE

$ETH

$IMX

$SHIB

$SOL

$XRP

Bitcoin Reclaims $91,000, Ethereum, XRP, Dogecoin Ride The Rally – 'BTC Doing What It Always Does'

Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) shares are rallying Tuesday, nearing all-time highs on continued momentum from strong earnings late last week. Here&#8217;s a look at <a href="https://www.benzinga.com/markets/equities/25/04/44919712/netflix-shares-up-1-6-after-key-signal-even-as-s-p-500-drops-2-4">what&#8217;s going on</a>.
What To Know: Netflix stock has been on a tear this week as investors flock to the name as a <a href="https://www.benzinga.com/trading-ideas/25/04/44909012/how-to-trade-the-one-tariff-proof-tech-stock">safe haven</a> amid tariff uncertainty. Netflix is largely insulated from global tariffs as the company sells streaming subscriptions as opposed to physical goods, and strong earnings from last week appears to have sparked investor confidence. 
Netflix reported first-quarter revenue of $10.54 billion, beating analyst estimates of $10.52 billion. The company reported first-quarter adjusted earnings of $6.61 per share, beating estimates of $5.74 per share, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Total revenue was up 13% year-over-year, driven by membership growth and higher pricing. The streaming giant said results came in above company expectations due to higher-than-forecasted subscription and advertising revenue.
Netflix guided for 15% revenue growth in the second quarter, highlighting continued strong trends in memberships and advertising revenue. The company also forecasted second-quarter earnings of $7.03 per share versus estimates of $6.27 per share.
"We remain optimistic about our 2025 slate with a lineup that includes returning favorites, series finales, new discoveries and unexpected surprises designed to thrill our members," the company said last week. 
Check This Out: <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44930495/wall-street-rebounds-ahead-of-tesla-earnings-dow-adds-1000-points-bitcoin-hits-91000-whats-driving-markets-tuesday">Wall Street Rebounds Ahead Of Tesla Earnings, Dow Adds 1,000 Points, Bitcoin Hits $91,000: What&#8217;s Driving Markets Tuesday?</a>
Following the print, several analysts <a href="https://www.benzinga.com/general/entertainment/25/04/44905838/netflix-playing-offense-while-stock-plays-defense-6-analysts-on-q1-results-advertising-growth-ahead">raised price targets</a> on the streaming stock, ranging from $1,070 to $1,514 per share. 
JPMorgan analysts flagged Netflix as a defensive play for investors, but also noted that the company is &#8220;playing offense.&#8221; The analyst firm believes Netflix will continue to be a key beneficiary of the ongoing disruption of linear TV. 
Several analysts acknowledged Netflix&#8217;s limited exposure to tariffs, suggesting minimal impacts from macroeconomic uncertainty. Many firms also pointed to strong subscriber growth trends and the ability for the company to raise prices and drive stronger revenue growth through its ad-tier plan. 
&#8220;Mgmt confirmed they are not seeing a slowdown or pullback in ad spend given recent macro uncertainty,&#8221; Macquarie analyst Ross Compton said. 
<a href="http://benzinga.com/quote/nflx">Netflix shares</a> reached all-time highs of $1,064.50 in February. The stock is up about 8% over the past few trading sessions and is now within striking distance of the February highs. 
Netflix shares were up 4.8% at $1,035.26 at the time of publication Tuesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/25/04/44905838/netflix-playing-offense-while-stock-plays-defense-6-analysts-on-q1-results-advertising-growth-ahead">Netflix &#8216;Playing Offense&#8217; While Stock Plays Defense: 6 Analysts On Q1 Results, Advertising Growth Ahead</a></li>
</ul>
Photo: FP Creative Stock/Shutterstock.

Analyst Color

Price Target

NFLX

Netflix Stock Nears All-Time High: What's Going On?

Roche Holdings AG (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RHHBY#OTC">RHHBY</a>) announced on Tuesday that it will invest $50 billion in the U.S. over <a href="https://www.benzinga.com/topic/pharmaceuticals">the next five years.</a>
These investments further strengthen Roche's already significant U.S. footprint, which includes 13 manufacturing and 15 R&amp;D sites across the Pharmaceutical and Diagnostics Divisions.
The investment is expected to <a href="https://www.roche.com/media/releases/med-cor-2025-04-22" target="_blank" rel="noreferrer noopener">create</a> over 12,000 new jobs, including nearly 6,500 construction jobs and 1,000 jobs at new and expanded facilities.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44724763/pharma-industry-faces-jitters-as-trump-hints-at-historic-tariffs-bofa-outlines-probable-timeline" rel="noreferrer noopener">Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline</a>
As part of this investment, Roche will increase its footprint of more than 25,000 employees in 24 sites across eight U.S. states. The investment will include: 
<ul>
<li>Expanded and upgraded US manufacturing and distribution capabilities for its innovative medicines and diagnostics portfolio in Kentucky, Indiana, New Jersey, Oregon, and California.</li>
<li>Gene therapy manufacturing facility in Pennsylvania.</li>
<li>A new 900,000-square-foot manufacturing center to support Roche's expanding portfolio of <a href="https://www.benzinga.com/general/biotech/25/04/44791986/whats-going-on-with-viking-therapeutics-structure-therapeutics-stock-on-monday" target="_blank" rel="noreferrer noopener">next-generation weight loss medicines</a>. The company says the location will be announced.</li>
<li>A new manufacturing facility for continuous glucose monitoring in Indiana.</li>
<li>A new R&amp;D center in Massachusetts for conducting artificial intelligence research and as a hub for new cardiovascular, renal, and metabolism R&amp;D efforts.</li>
<li>Significant expansion and upgrading of existing pharmaceuticals and diagnostics R&amp;D centers in Arizona, Indiana, and California.</li>
</ul>
Once all new and expanded manufacturing capacity comes online, Roche will export more medicines from the U.S. than it imports. The company says its diagnostics division already has an export surplus from the U.S. to other countries.
Earlier this month, Novartis AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>) unveiled a sweeping $23 billion investment plan to expand its manufacturing and research infrastructure in the U.S. <a href="https://www.benzinga.com/general/biotech/25/04/44761201/novartis-commits-23-billion-to-expand-us-manufacturing-over-five-years-despite-tariffs-uncertainties" target="_blank" rel="noreferrer noopener">over the next five years</a>.
The move is part of a broader strategy to ensure that all key Novartis medicines for U.S. patients are produced domestically.
Earlier this year, Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) announced its plans to invest more than <a href="https://www.benzinga.com/markets/equities/25/03/44433978/johnson-johnson-to-invest-55-billion-in-us-to-boost-manufacturing-drug-discovery" target="_blank" rel="noreferrer noopener">$55 billion in the U.S. over the next four years</a>, while Eli Lilly And Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) plans to double its U.S. drug manufacturing spending from $23 billion to <a href="https://www.benzinga.com/general/biotech/25/02/43982604/eli-lilly-doubles-capital-spending-on-us-drug-manufacturing-with-50-billion-target" target="_blank" rel="noreferrer noopener">$50 billion within five years</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/asset-sales/25/04/44929060/boeing-finalizes-10-55-billion-deal-to-divest-jeppesen-and-foreflight-assets" target="_blank" rel="noreferrer noopener">Boeing Finalizes $10.55 Billion Deal To Divest Jeppesen And ForeFlight Assets</a></li>
</ul>
Photo: Gorodenkoff/Shutterstock

Biotech

Health Care

RHHBY

Roche Plans $50 Billion US Investment Over 5 Years With 12,000 New Jobs

On Tuesday, Sapiens International Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPNS#NASDAQ">SPNS</a>) disclosed its plan to acquire Candela for an aggregate <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/n44915217/sapiens-acquires-candela-to-expand-its-footprint-in-apac-and-enhance-its-life-product-portfolio" rel="noreferrer noopener">cash consideration of&nbsp;$22 million</a>.
Candela offers an end-to-end insurance automation platform along with digital services and solutions in the APAC region.
The acquisition is intended to strengthen Sapiens' life insurance offerings and broaden its footprint across Asia-Pacific.
The deal is anticipated to close in the second quarter of 2025, pending regulatory approvals and closing conditions.
Candela's offerings complement Sapiens' Insurance Platform and Life Policy Administration Systems.
By integrating Candela's strengths in Business Process Modelling (BPM) and Case Management, Sapiens plans to enhance its life insurance solutions.
The acquisition will also allow for the integration of standardized workflows across third-party legacy systems, delivering a more streamlined and consistent experience for agents, customers, and administrators.
Roni Al-Dor, CEO and President at Sapiens, said, "We will continue to support Candela's customers and products, increasing value across the entire insurance lifecycle and supporting insurers' digital transformations with a comprehensive product proposition and a diverse range of service capabilities."
Amitabh Poddar, Business Head at Candela, added, "Integrating our intelligent automation solutions into Sapiens' leading insurance software platform will enhance our capabilities and provide even greater value to our customers."
Notably, Candela reported non-GAAP revenues of $8 million for the full year 2024. The transaction is expected to be accretive to Sapiens' profitability <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">beginning in the fourth quarter of 2025</a>.
The deal is expected in the second quarter of 2025 and Candela will operate as a wholly owned subsidiary of Sapiens.
The company disclosed the first quarter of<a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener"> 2025 results on May 8, 2025</a>.
As of December 31, cash and cash <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n43775499/sapiens-reports-fourth-quarter-2024-financial-results" rel="noreferrer noopener">equivalent stood at $163.7 million</a>.
Investors can gain exposure to the stock via ARK Israel Innovative Technology ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/IZRL#BATS">IZRL</a>).
Price Action: SPNS shares are up 3.30% at $26.28 at the last check on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/25/04/44911125/dan-loebs-bet-on-taiwan-semiconductor-looks-strong-as-q1-results-top-expectations" target="_blank" rel="noreferrer noopener">Dan Loeb's Bet On Taiwan Semiconductor Looks Strong As Q1 Results Top Expectations</a></li>
</ul>
Photo via Shutterstock

Equities

Small Cap

IZRL

SPNS

Sapiens Taps APAC Growth With $22 Million Candela Acquisition

WIIM

Shares of retail and consumer discretionary stocks are trading higher following US Treasury Secretary Scott Bessent's reported remarks about trade de-escalation with China. De-escalation with China could reduce supply chain uncertainty and boost consumer sentiment.

Cantor Fitzgerald initiated coverage on Eli Lilly And Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) on Monday, citing orforglipron data, which strengthens <a href="https://www.benzinga.com/topic/weight-loss" target="_blank" rel="noreferrer noopener">the case for obesity dominance</a>.
Last week, the U.S. drug giant reported topline Phase 3 results from the ACHIEVE-1 trial of orforglipron compared to placebo in adults with type 2 diabetes and inadequate glycemic control with <a href="https://www.benzinga.com/25/04/44860903/eli-lillys-oral-glp-1-drug-orforglipron-hits-phase-3-goals-in-diabetes-trial-stock-shoots-higher" target="_blank" rel="noreferrer noopener">diet and exercise alone</a>.
In the first Phase 3 trial of the ACHIEVE program, orforglipron met the primary endpoint of superior A1C (blood sugar) reduction compared to placebo at 40 weeks, lowering A1C by an average of 1.3% to 1.6% from a baseline of 8.0%,&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/25/04/44871681/lillys-diabetes-pill-clears-major-trial-analyst-points-to-global-potential" rel="noreferrer noopener">using the efficacy estimand</a>.
After a choppy second half of 2024, &#8220;Lilly is off to a solid start in &#8217;25,&#8221; Cantor analyst Carter Gould writes. The company reported positive orforglipron ACHIEVE-1 data and improved underlying GLP-1 commercial metrics. 
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44907170/upcoming-pfizer-earnings-call-might-be-focused-on-tariffs-policy-risks-and-obesity-pipeline" rel="noreferrer noopener">Upcoming Pfizer Earnings Call Might Be Focused On Tariffs, Policy Risks And Obesity Pipeline</a>
&#8220;&#8230;We view the ACHIEVE-1 data as meaningfully de-risking a 13-16% weight loss profile, and if safety/tolerability holds up, it should leave LLY well-positioned to take share from semaglutide and further grow the market with an oral approach,&#8221; analyst Gould adds.
Cantor writes that Eli Lilly could have an over 85% share of the obesity market by 2029-2030E when the next wave of entrants hits. Cantor initiated with an Overweight rating and a <a target="_blank" href="https://www.benzinga.com/quote/LLY/analyst-ratings" rel="noreferrer noopener">price target of $975</a>.
Eli Lilly&#8217;s first-quarter earnings are in the front row for investors.
The company is scheduled to release the financial performance on 1 May. Analysts expect $4.79 per share earnings with <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">sales of $12.93 billion</a>.
Cantor expects modest beats across Mounjaro/Zepbound and that the company will likely reaffirm the FY25 topline guide ($59-61 billion) as a raise is more likely after the second quarter of 2025.
In March, the company announced the launch of its popular weight loss drug Mounjaro (tirzepatide) in India, which is expected to have the second-largest population of overweight or&nbsp;<a target="_blank" href="https://www.benzinga.com/25/04/44824190/eli-lillys-mounjaro-launch-triggers-weight-loss-craze-in-india-novo-nordisk-seeks-to-move-up-wegovy-launch" rel="noreferrer noopener">obese people by 2050</a>.
Rival&nbsp;Novo Nordisk A/S&#8217;&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) is feeling the pressure as it tries to move up the launch of Wegovy in India to better compete with Lilly.
BofA Securities has also made minor changes to its model for Eli Lilly ahead of Q1 earnings.
BofA analyst Tim Anderson writes that IQVIA recently began including Lilly Direct vials in its TRx (total prescription) data. As for pricing, Eli Lilly expects an overall price decline by the mid-to-high single digits in 2025. While this isn&#8217;t specific to any product, the company suggests that falling prices for its obesity drugs will likely be a major factor.
For 2025/2026, revenues are changed by +1%/+0.4%, and EPS estimates change by +1.9%/-0.7%. No substantial changes to Mounjaro/Zepbound forecasts.
BofA reiterates the Buy rating with a price target of $1,000. &#8220;We continue to like LLY, not &#8220;expensive&#8221; on a PE-to-growth basis, by our math.&#8221;
Price Action: LLY stock is up 0.59% at $822.84 at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/guidance/25/04/44928828/devon-energy-unveils-1-billion-annual-optimization-plan-targets-efficiency-gains-by-2026" target="_blank" rel="noreferrer noopener">Devon Energy Unveils $1 Billion Annual Optimization Plan, Targets Efficiency Gains By 2026</a></li>
</ul>
Image: Shutterstock

Initiation

Analyst Ratings

Eli Lilly Positioned To Dominate Obesity Market With Oral Option, Analyst Initiates With Confidence

On 4/20, while most were lighting up, Snoop Dogg dropped a trip—visually speaking.
Directed by Dave Meyers and produced by Psyop in collaboration with Temple Caché, the music video for &#8220;Last Dance with Mary Jane&#8220;—Snoop's cannabis-laced reimagining of the Tom Petty classic—takes viewers on a mind-bending ride through the rapper's life, inner cities and stoner dreams. The track, from Snoop's &#8220;Missionary&#8221; album, released last year via Death Row, Aftermath and Interscope, features Jelly Roll, cameos by B-Real, Method Man, Redman, Wiz Khalifa and even visual nods to Bob Marley, Tupac and Tom Petty himself.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Last Dance with Mary Jane ft. Tom Petty &amp; Jelly Roll (Official Music Video)" width="500" height="281" src="https://www.youtube.com/embed/rseqmSGH7xk?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
This isn't your typical hip-hop video; it's a genre-smashing blend of handcrafted animation and generative AI, layered across a semi-autobiographical storyline about Snoop's lifelong relationship with cannabis and the justice issues it invokes.
"Being able to partner with Dre, Snoop and Dave to create a visual style that hasn't been done is exactly the type of project we live for," said Joe Maggiore of Psyop.
The visuals? Insane. Think 2D, 3D, collage, motion design and surreal AI landscapes. But it's not AI doing the storytelling—every frame was touched by human hands, ensuring emotional nuance and a narrative throughline. "Storytelling requires nuance," said Psyop's Andrew Linsk, explaining why AI alone couldn't carry the vision.
The end result is both a love letter to cannabis and a statement on America—its cities, its culture, its contradictions.
<h2 class="wp-block-heading">Meanwhile… Jet Black Roses Go Full Funkadelic</h2>
If Snoop's video is a lucid dream, Jet Black Roses' new single is a fever-drenched backyard boogie. Its latest track, &#8220;Psychoboogie Hoochiecoo,&#8221; arrives with a brain-melting video by Steffan Heil (of Adult Swim fame) and production by Greg Archilla (Neil Young, Collective Soul, Matchbox Twenty).
No AI. No autotune. Just brass, groove and sweat.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="PsychoBoogieHoochieCoo (Official Music Video)" width="500" height="281" src="https://www.youtube.com/embed/DlQuGfovDEg?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
MusicRow nailed it: "Funky, horn-punctuated Southern rock with some built-in grease."
The band describes itself as the &#8220;Coolest Dad Rock Band in America,&#8221; but that barely scratches it. Picture the swagger of Little Feat, the freak of Funkadelic and the slink of The Meters—wrapped in Jet Black Roses' Louisiana-born harmonies and storytelling.
It&#8217;s shared stages with Styx, Sammy Hagar and Collective Soul. It&#8217;s not riding genre trends. It&#8217;s playing from the gut—and it shows.
It&#8217;s 2025 is just getting started.
Lead image courtesy of Psyop

Cannabis

Entertainment

Snoop Dogg's 'Last Dance' Is Cannabis Cinema At Its Weirdest—And There's A Funkadelic 'Dad Rock' Counterpart

SCCO

TECK

VALE

Shares of metals and materials stocks are trading higher following US Treasury Secretary Scott Bessent's reported remarks about trade de-escalation with China. De-escalation with China could reduce demand uncertainty.

Shares of Tivic Health Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) are soaring Tuesday after the company announced it held senior-level briefings with White House officials and the U.S. Food and Drug Administration (FDA), which resulted in strong interest in potential military and defense <a href="https://www.benzinga.com/pressreleases/25/04/b44920336/tivic-health-reports-white-house-briefing-and-fda-meetings-secured-positive-interest-in-potential-">product candidates</a>.
What To Know: Tivic disclosed that it presented its therapeutic programs to senior leadership at the White House and FDA on Thursday. Discussions centered around the company's TLR5 and non-invasive cervical vagus nerve stimulation (ncVNS) programs. 
The White House meeting focused on the TLR5 program and its lead product candidate, Entolimod, which is being developed to treat acute radiation syndrome. The briefing addressed the need for better treatment options for radiation exposure and highlighted Entolimod's role in enhancing immune response through the TLR5 pathway, which is part of the body's innate immune system.
The company noted that Entolimod previously received significant development funding from various U.S. government agencies, including BARDA, NASA, the Defense Threat Reduction Agency, the Department of the Army and the Department of Defense. Tivic emphasized the potential for Entolimod to offer advantages over current treatments, such as providing gastrointestinal and hematopoietic protection from radiation in a single dose.
In a separate meeting, Tivic met with senior leadership at the FDA to discuss potential expedited regulatory pathways for both Entolimod and Entolasta, a second-generation TLR5 agonist. 
The company also presented its ncVNS program to the FDA, which is targeting a range of inflammatory, cardiac and neurologic conditions. The FDA gave favorable feedback, including potential support for breakthrough device designation upon completion of relevant clinical work.
&#8220;We deeply appreciated the opportunity to discuss the importance of our clinical pipeline in potentially protecting and healing both active and retired military personnel, first responders, as well as U.S. citizens and our allies,&#8221; said Jennifer Ernst, CEO of Tivic Health.
&#8220;While these meetings were informal in nature, we expect to continue these discussions as Entolimod and our ncVNS medical programs progress toward potential FDA approval.&#8221;
TIVC Price Action: Tivic Health shares traded as high as $13.23 on Tuesday. The stock was up 107.7% at $7.28 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2"><img loading="lazy" decoding="async" width="1024" height="543" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/22134226/Screenshot-2025-04-22-at-13.42.06-1024x543.png" alt="" class="wp-image-882548" style="width:476px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/22134226/Screenshot-2025-04-22-at-13.42.06-1024x543.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/22134226/Screenshot-2025-04-22-at-13.42.06-300x159.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/22134226/Screenshot-2025-04-22-at-13.42.06-768x407.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/22134226/Screenshot-2025-04-22-at-13.42.06.png 1496w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44930495/wall-street-rebounds-ahead-of-tesla-earnings-dow-adds-1000-points-bitcoin-hits-91000-whats-driving-markets-tuesday">Wall Street Rebounds Ahead Of Tesla Earnings, Dow Adds 1,000 Points, Bitcoin Hits $91,000: What&#8217;s Driving Markets Tuesday?</a></li>
</ul>
Image via Shutterstock.

TIVC

Tivic Health Systems Stock Is On Fire Today: What's Going On?

Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), considered a proxy for large-cap growth and tech-dense innovation, faltered considerably in 2025.
What Happened: The ETF has had year-to-date losses of 13.44%. While alarming on its own, this number conceals more profound undercurrents within its<a href="https://www.benzinga.com/etfs"> underlying makeup</a>, most notably the fortunes of &#8220;Magnificent Seven&#8221; stocks, which collectively comprise more than 40% of the QQQ.
The decline among these mega-cap growth stars has been swift and, by some accounts, historic. Roundhill Magnificent Seven ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/MAGS#BATS">MAGS</a>) mirrors this group of stocks and is down over 12% for the past six months.
As investment advisory company Bespoke Investment Group recently<a href="https://www.benzinga.com/25/04/44916598/tariff-pause-fizzles-mag-7-stocks-slide-back-to-pre-pause-lows"> noted, there is more downside risk</a>.
Also Read: <a href="https://www.benzinga.com/etfs/specialty-etfs/25/04/44895562/3-high-risk-etfs-aggressive-retail-investors-cant-stop-buying">3 High-Risk ETFs Aggressive Retail Investors Can&#8217;t Stop Buying</a>
A convergence of global macroeconomic headwinds has helped to bring about this weakness. J.P. Morgan Asset Management <a href="https://www.advisorpedia.com/markets/can-mega-cap-tech-stocks-withstand-the-tariff-pressure/">underscores </a>that around 75% of the suppliers to these companies are overseas, many in jurisdictions that are newly subject to fresh tariffs under new U.S. trade policy. 
Adding to the squeeze, corporate behemoths and Mag7 members such as Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), and Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) get more than half of their revenues abroad. Consequently, rising trade tensions and supply chain risks continue to be primary risk considerations for investors assessing exposure to QQQ or its underlying tech giants.
Why It Matters: A wider view presents a more complex picture. According <a href="https://www.advisorpedia.com/markets/can-mega-cap-tech-stocks-withstand-the-tariff-pressure/">to </a>J.P. Morgan&#8217;s Stephanie Aliaga, the recent decline has not been caused by a deterioration in underlying fundamentals. 
Instead, it is a repricing of risk in the face of heightened uncertainty regarding margins, capital spending, and earnings expectations. This has resulted in significant compression in valuation. 
Importantly, the forward price-to-earnings (P/E) multiple for the Magnificent Seven has fallen from around 31x early in the year to about 22x—its lowest price since January 2023, before the then-ongoing artificial intelligence (AI) cycle of investment.
This relative discount may attract long-term investors looking for quality at a better entry point. These companies are at the core of the QQQ portfolio and leading in innovation, especially in AI and cloud computing. Their impact on the overall market, and the QQQ, is still unbroken.
However, near-term prudence is likely to be justified. Trade headwinds are not likely to subside quickly, and more volatility in mega-cap growth can be expected. But for those with the stomach for short-term dislocations, the combination of cheap valuations and continued innovation leadership presents an attractive argument for revisiting QQQ and its Mag 7 exposure.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/new-etfs/25/04/44933272/rnty-yieldmaxs-bold-new-real-estate-etf-that-builds-income-one-option-at-a-time">RNTY: YieldMax&#8217;s Bold New Real Estate ETF That Builds Income, One Option At A Time</a></li>
</ul>
Image: Shutterstock

Specialty ETFs

ETFs

GOOGL

MAGS

MSFT

Magnificent Meltdown: QQQ Tanks As Big Tech's Shine Wears Off, But There's A Silver Lining

AIRT

ARRY

AZEK

CARR

Embraer-Empresa Brasileira De Aeronautica

EVTL

HAYW

HLGN

JBHT

LDOS

MATX

NRGV

ODFL

PCAR

SAIA

SHLS

TREX

UHAL

Shares of companies in the broader industrial sector are trading higher following US Treasury Secretary Scott Bessent's reported remarks about trade de-escalation with China.

CMCSA

Xfinity Mobile Reveals New Premium Unlimited Plan That Delivers Gigabit Speeds And Upgraded Features

Old Second Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSBC#NASDAQ">OSBC</a>) will release its quarterly earnings report on Wednesday, 2025-04-23. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Old Second Bancorp to report an earnings per share (EPS) of $0.44.
Anticipation surrounds Old Second Bancorp's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Earnings Track Record</h3>
During the last quarter, the company reported an EPS missed by $0.04, leading to a 2.41% drop in the share price on the subsequent day.
Here's a look at Old Second Bancorp's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.48</td>
<td>0.47</td>
<td>0.47</td>
<td>0.46</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.44</td>
<td>0.51</td>
<td>0.46</td>
<td>0.47</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-2.0%</td>
<td>6.0%</td>
<td>-2.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745348609_0.png" alt="eps graph" />
<h3>Old Second Bancorp Share Price Analysis</h3>
Shares of Old Second Bancorp were trading at $14.68 as of April 21. Over the last 52-week period, shares are up 4.66%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/OSBC/earnings">To track all earnings releases for Old Second Bancorp visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

OSBC

An Overview of Old Second Bancorp's Earnings

Press Releases

TriSalus Life Sciences® Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav® Infusion System to U.S. Veterans with Liver Cancer

TriSalus Reports Q3 2024 Financial Results and Provides Business Update

TriSalus Announces Leadership Changes

TriSalus Life Sciences® Announces Publication of Pre-Clinical Data Demonstrating Improved Delivery of Embospheres® to Liver Tumors using Pressure-Enabled Drug Delivery™ (PEDD™) via the TriNav® Infusion System

TriSalus Life Sciences Announces Preliminary Q4 and Full Year Unaudited 2024 Financial Results and Conference Call

TriSalus Life Sciences Announces Drawdown of $10 Million Tranche Under Credit Agreement with OrbiMed

TriSalus Life Sciences Announces Key Appointments to Board of Directors

TriSalus Life Sciences® Announces That Its Researchers Received Two JVIR Top Paper Awards for the Publication of "Intra-arterial Pressure-Enabled Drug Delivery™ Significantly Increases Penetration of Glass Microspheres in a Porcine Liver Tumor Model"

TriSalus Life Sciences Announces New CMS HCPCS Code for TriNav® Infusion System Mapping

TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update

Comments

TriSalus Life Sciences

Vendite allo scoperto

TriSalus Life Sciences (NASDAQ:TLSI) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO